Potential novel target drugs for anti-ovarian cancer targeted therapies:research advances / 国际药学研究杂志

Molecular target therapy plays an important role in the treatment of malignant tumor.But research and development progress is slow on drugs targeting ovarian cancer.Only bevacizumab and olaparib have been approved for treating ovarian cancer by the FDA or the EMA,and their clinical application is limited.In recent years,there have been more and more reports on molecular tar?get therapy of ovarian cancer.Research advances have been made on novel drugs targeting E3 ubiquitin ligase,VEGF/VEGFR signal?ing pathways,PD-1/PD-L1 signaling pathways,IL-6/IL-6R signaling pathways and macrophage migration-inhibitory factor.This arti?cle briefly summarizes the current progresses in studies of molecular target therapy in ovarian cancer.